Imagion Biosystems Limited ASX: IBX A S X A N N O U N C E M E N T | 2 6 O c t o b e r 2 0 2 6 Amended Appendix 4C – September 2026 Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its...
Amended Appendix 4C - September 2026
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Story so far
Earlier from Imagion Biosystems
- Appendix 4C and Quarterly Activities Report - September 2026
- IBX Secures Central Ethics Approval - Key Phase 2 Milestone
- Imagion Resumes MagSense® Nanoparticle Manufacturing Capabilities
- MagSense Nanoparticle Manufacturing Update
- IBX Investor Presentation
Later from Imagion Biosystems
All Imagion Biosystems news releasesFollow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems